Ginsenoside CK Inhibits TGF-β-Induced Epithelial-Mesenchymal Transition in A549 Cell via SIRT1

Ginsenoside CK Inhibits Hypoxia-Induced Epithelial–Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma

(2021) Jingjing Zhang et al.   Foods

20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1

(2019) Yuchen Wang et al.   Frontiers in Pharmacology

Ginsenoside Compound K Induces Ros-Mediated Apoptosis and Autophagic Inhibition in Human Neuroblastoma Cells In Vitro and In Vivo

(2019) Jung-Mi Oh et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Understanding the Global Cancer Statistics 2018: implications for cancer control

(2019) Zijie Cai et al.   Science China-Life Sciences

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial–mesenchymal transition and stemness

(2018) Jingjing Wang et al.   CANCER LETTERS

Compound K, a ginsenoside metabolite, plays an antiinflammatory role in macrophages by targeting the AKT1-mediated signaling pathway

(2018) Jeong-Oog Lee et al.   Journal of Ginseng Research

Prognostic and clinicopathological significance of SIRT1 expression in NSCLC: a meta-analysis

(2017) Yifei Chen et al.   Oncotarget

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EMT: 2016

(2016) M. Angela Nieto et al.   CELL

Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis

(2016) Ching-Wen Lin et al.   Nature Communications

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1

(2016) Byong-Ki Cha et al.   Oncotarget

A review of biotransformation and pharmacology of ginsenoside compound K

(2015) Xi-Ding Yang et al.   FITOTERAPIA

Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism

(2015) Glenn Simmons et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer

(2015) Keqiang Zhang et al.   PHARMACEUTICAL BIOLOGY

Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4

(2015) Lili Tian et al.   Oncotarget

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma

(2015) Chong Hao et al.   BMC CANCER

Endothelial Cell-Secreted EGF Induces Epithelial to Mesenchymal Transition and Endows Head and Neck Cancer Cells with Stem-like Phenotype

(2014) Z. Zhang et al.   CANCER RESEARCH

Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis

(2014) I-Chieh Chen et al.   Molecular Cancer

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells

(2014) Jeannine Diesch et al.   PLoS One

MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells

(2013) Lihua Zhang et al.   BMC CANCER

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells

(2013) Yan Chen et al.   Cancer Cell International

Up-Regulation of MBD1 Promotes Pancreatic Cancer Cell Epithelial-Mesenchymal Transition and Invasion by Epigenetic Down-Regulation of E-Cadherin

(2013) J. Xu et al.   CURRENT MOLECULAR MEDICINE

Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions

(2013) Zhiyu Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer

(2013) Sang Jae Noh et al.   PATHOLOGY RESEARCH AND PRACTICE

Epithelial–mesenchymal transition in lung development and disease: does it exist and is it important?

(2013) Domokos Bartis et al.   THORAX

Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma

(2012) Si-Hyong Jang et al.   JOURNAL OF CLINICAL PATHOLOGY

Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis

(2012) Sylvie Rodrigues-Ferreira et al.   PLoS One

Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng

(2012) Dong-Hyun Kim   Journal of Ginseng Research

TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

(2011) M. K. Asiedu et al.   CANCER RESEARCH

IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway

(2011) A. Yadav et al.   MOLECULAR CANCER RESEARCH

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol

(2009) G Boily et al.   ONCOGENE